Overview
Erin Ezzell is a Hematologist Oncology specialist and a Hematologist in Norman, Oklahoma. Dr. Ezzell is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, and Paget Disease of the Breast. Dr. Ezzell is currently accepting new patients.
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
901 N Porter Ave, Norman, OK 73071
900 Ne 10th St, Ouhp Family Medicine, Oklahoma City, OK 73104
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ou Health Partners Inc
Jennifer O'stasik is an Oncologist and a Hematologist in Oklahoma City, Oklahoma. Dr. O'stasik is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. Dr. O'stasik is currently accepting new patients.
Ou Health Partners Inc
Raid Aljumaily is a Hematologist and an Oncologist in Oklahoma City, Oklahoma. Dr. Aljumaily is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma.
Mercy Clinic Oklahoma Communities
Jess Armor is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Armor is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Large-Cell Immunoblastic Lymphoma, Multiple Myeloma, Primary Lymphoma of the Brain, and Bone Marrow Aspiration. Dr. Armor is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Ezzell isAdvanced. Learn about Breast Cancer.
- Lung CancerDr. Ezzell isAdvanced. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Ezzell isAdvanced. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Ezzell isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Ezzell isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Ezzell isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Ezzell isExperienced. Learn about Anal Cancer.
- Angioimmunoblastic T-cell LymphomaDr. Ezzell isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- AngiosarcomaDr. Ezzell isExperienced. Learn about Angiosarcoma.
- Antiphospholipid SyndromeDr. Ezzell isExperienced. Learn about Antiphospholipid Syndrome.